Lifestyle behaviours and health measures of women at increased risk of breast cancer taking chemoprevention.
Affiliation
Division of Cancer Sciences, Faculty of Biology, Medicine and HealthPrevent Breast Cancer Research Unit, The Nightingale Centre, Wythenshawe HospitalIssue Date
2018
Metadata
Show full item recordAbstract
Women at increased breast cancer (BC) risk are eligible for chemoprevention. Healthy lifestyles are potentially important for these women to improve efficacy and minimise side effects of chemoprevention and reduce the risk of BC and other lifestyle-related conditions. We investigated whether women taking chemoprevention adhere to healthy lifestyle recommendations, how their lifestyle risk factors and health measures compare to women in the general population, and whether these change whilst taking chemoprevention. Lifestyle risk factors and health measures in 136 premenopausal women taking tamoxifen for prevention of BC (Tam-Prev study) were compared to both national recommendations and an age-matched female population from the Health Survey for England 2012. The Tam-Prev population had high rates of overweight and obesity (59.2%) and low adherence to physical activity recommendations (30.6%) which were comparable to the general population (55.2 and 35.1%, respectively). Fewer Tam-Prev participants were current smokers (10.5 vs. 18.2%, P=0.032), but more exceeded alcohol recommendations (45.0 vs. 18.7%, P<0.001). Tam-Prev participants had suboptimal diets; proportions not meeting fibre, saturated fat and non-milk extrinsic sugar recommendations were 87.8, 64.9 and 21.4% respectively. Many Tam-Prev participants had markers of cardiovascular disease risk and the metabolic syndrome. Health behaviours did not change during the first year on tamoxifen. Women taking chemoprevention had a high prevalence of unhealthy lifestyle behaviours and health measures, similar to an age-matched English cohort. Improving these measures in women at increased BC risk could significantly decrease rates of BC and other noncommunicable diseases.Citation
Pegington M, Evans DG, Howell A, Donnelly LS, Wiseman J, Cuzick JM, et al. Lifestyle behaviours and health measures of women at increased risk of breast cancer taking chemoprevention. Eur J Cancer Prev. 2018 Nov 15.Journal
European Journal of CancerDOI
10.1097/CEJ.0000000000000493PubMed ID
30444752Additional Links
https://dx.doi.org/10.1097/CEJ.0000000000000493Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1097/CEJ.0000000000000493
Scopus Count
Collections
Related articles
- Improved Uptake and Adherence to Risk-Reducing Medication with the Use of Low-Dose Tamoxifen in Patients at High Risk for Breast Cancer.
- Authors: Cornell LF, Klassen CL, Ghosh K, Ball C, Advani P, Pruthi S
- Issue date: 2024 Dec 3
- Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.
- Authors: Land SR, Cronin WM, Wickerham DL, Costantino JP, Christian NJ, Klein WM, Ganz PA
- Issue date: 2011 Sep
- Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.
- Authors: Waters EA, McNeel TS, Stevens WM, Freedman AN
- Issue date: 2012 Jul
- Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.
- Authors: Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH
- Issue date: 2003 Apr 2
- Chemoprevention of breast cancer.
- Authors: Thomsen A, Kolesar JM
- Issue date: 2008 Dec 1